OTC Markets OTCQB - Delayed Quote • USD Telescope Innovations Corp. (TELIF) Follow Compare 0.2900 -0.0002 (-0.07%) At close: January 10 at 3:00:00 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Telescope Innovations Presents Continued Growth in Fiscal Year 2024 Increased revenues fueled major research and commercialization projects for intelligent automation products and advanced chemical manufacturing Vancouver, British Columbia--(Newsfile Corp. - December 23, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal year ended August 31, 2024. The Company generated reven General Copper Gold And 2 Other TSX Penny Stocks To Watch The Canadian market has been navigating a landscape of economic shifts and evolving investor sentiment, reflecting broader global trends. Despite the vintage feel of the term "penny stocks," these investments remain relevant as they often represent smaller or newer companies with potential for significant returns. In this article, we explore three TSX penny stocks that showcase financial strength and offer intriguing opportunities for investors seeking hidden value in quality companies. Telescope Innovations Announces Scientific Publication on AI-Optimized Production of Battery-Grade Lithium Carbonate AI guides Telescope's ReCRFT tech to boost efficiency and environmental sustainability of producing battery raw materials Vancouver, British Columbia--(Newsfile Corp. - October 29, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company"), a developer of enabling technologies for the global pharmaceutical and chemical industries, is pleased to announce the publication of a collaborative research project in Digital Discovery. The peer-reviewed paper 3 TSX Penny Stocks With Market Caps Under CA$200M To Watch The Canadian market has remained flat over the past week but is up 27% over the last year, with earnings projected to grow by 16% annually. In such a climate, identifying stocks that combine value and growth potential becomes crucial, especially among smaller or newer companies often labeled as penny stocks. Despite being somewhat of an outdated term, penny stocks can still offer substantial opportunities when supported by strong financials; this article will highlight several that stand out... Telescope Innovations Becomes Certified Systems Integrator of Universal Robots Certification enables faster development and deployment of Telescope's Self-Driving Labs Vancouver, British Columbia--(Newsfile Corp. - October 15, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company"), a developer of enabling technologies and services for the global pharmaceutical and chemical industries, announces its achievement of Certified Systems Integrator ("CSI") status for robotic instruments sold by Universal Robots ("UR"). UR has eme Telescope Innovations and Altillion Inc. Showcase Proprietary, Simplified Production of Battery-Quality Lithium Carbonate from Brines Telescope's proprietary ReCRFT process produces >99.5% pure lithium carbonate from Altillion's brine concentrates Vancouver, British Columbia--(Newsfile Corp. - September 17, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces the successful outcome of a research engagement with Altillion, Inc. ("Altillion") an innovator Telescope Innovations and Standard Lithium Demonstrate Low-Temperature, High-Purity Production of Lithium Sulfide for Solid-State Batteries Vancouver, British Columbia--(Newsfile Corp. - August 28, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces the successful outcome of a research collaboration with Standard Lithium Ltd. (TSXV: SLI) (NYSE American: SLI) ("Standard Lithium").Over the past year, Telescope Innovations and Standard Lithium have worked toget Telescope Innovations and Pfizer Sign Master Collaborative Research Agreement Funding from and collaboration with Pfizer could facilitate Telescope's growth and R&D advancement Vancouver, British Columbia--(Newsfile Corp. - July 31, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies and services for the global pharmaceutical and chemical industries, is pleased to announce the execution of a master collaborative research agreement (the "Agreement") with Pfizer Inc. ("Pfizer"). Under the multi- Telescope Innovations Receives CICE Funding to Pilot Lithium Refinement Technology Vancouver, British Columbia--(Newsfile Corp. - July 22, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been awarded $400,273 in early-stage funding from the B.C. Centre for Innovation and Clean Energy ("CICE"). This non-dilutive investment will support Telescope's piloting of its proprietary Recrystallization Refinement Technology ("ReCRFT™" Telescope Innovations Presents Results of Third Fiscal Quarter 2024 Year-to-date revenues surpass entire fiscal year 2023 Vancouver, British Columbia--(Newsfile Corp. - July 11, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended May 31, 2024. The Company generated revenues of $1.2 million during this period (Q3, 2024). Telescope's corresponding fiscal year-to-da Telescope Innovations Joins MaRS: North America's Largest Urban Innovation Hub Vancouver, British Columbia--(Newsfile Corp. - June 24, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been accepted as a member of MaRS Discovery District, ("MaRS") a network of the most promising and innovative young technology companies in Canada. As North America's largest urban innovation hub, MaRS empowers member companies to generate Telescope Innovations to Participate in Lithium Supply and Battery Raw Materials Conference 2024 Vancouver, British Columbia--(Newsfile Corp. - June 11, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, is pleased to announce its participation the 2024 Lithium Supply and Battery Raw Materials Conference hosted by Fastmarkets. The conference will take place on June 24-27 in Las Vegas, NV. Dr. Ryan Jansonius, VP of Chemistry Contract Services fo Telescope Innovations to Showcase DirectInject-LC(TM) Product and Process IP at METTLER TOLEDO Events Vancouver, British Columbia--(Newsfile Corp. - May 13, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, is pleased to announce its participation in two "InfoDays" sponsored by METTLER TOLEDO. Telescope will feature two proprietary innovations during the New Jersey and Montreal InfoDays. InfoDays are high-profile industry and academia networking ev Telescope Innovations Presents Results of Second Fiscal Quarter 2024 Vancouver, British Columbia--(Newsfile Corp. - April 18, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results and operational highlights for the fiscal quarter ended February 29, 2024. The Company generated revenues of $686,205 during this period, driven by strong sales performance of its flagship product, DirectInject-LC™. O Telescope Innovations Develops Novel Battery Recycling Technology A new approach isolates lithium and valuable transition metals from battery recycling feeds Vancouver, British Columbia--(Newsfile Corp. - April 15, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company") is leading a developer of advanced technologies and services for the global pharmaceutical and chemical industries. The Company focuses on process innovation, particularly for the production of medicinal compounds and battery materials. Telescope announces Telescope Innovations and Shimadzu Scientific Instruments Initiate Technology Partnership Telescope pairs its DirectInject-LC(TM) technology with Shimadzu's chemical analysis instrumentation Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies for the global pharmaceutical and chemical industries, announces that it is engaged in a technology integration partnership with Shimadzu Scientific Instruments, Inc. ("Shimadzu"). Shimadzu is a global leade Telescope Innovations Strengthens Senior Management: Henry Dubina Appointed as CEO, Dr. Jason Hein as CTO, John Kirincic as CFO, Deborah Cotter as Corporate Secretary Vancouver, British Columbia--(Newsfile Corp. - February 15, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies for the global pharmaceutical and chemical industries, is pleased to welcome Henry Dubina as Chairman and Chief Executive Officer and John Kirincic as Chief Financial Officer for the Company. Jason Hein will continue to lead Telescope's development services and research efforts as Chief Technology Officer, Mettler Toledo and Telescope Innovations Agree to Globally Distribute Telescope's Flagship Product, DirectInject-LC(TM) Vancouver, British Columbia--(Newsfile Corp. - February 5, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies for the global pharmaceutical and chemical industries, announces it has signed a Distribution Agreement with METTLER TOLEDO (NYSE: MTD) for Telescope's online chemistry sampling and analysis product, the DirectInject-LC™. METTLER TOLEDO is a global leader of precision instruments and services, including auto Telescope Innovations Presents Results of First Fiscal Quarter 2024 The Company exceeded its quarterly revenue and profit records in Q1, 2024 Vancouver, British Columbia--(Newsfile Corp. - January 30, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended November 30, 2023. The Company generated revenues of $1.50 M for a net income of $215,000 (Figure 1). Figure 1. Telescope Innovations Files Game-Changing Provisional Patent to Purify Battery Materials A novel refinement process generates battery-quality lithium carbonate in a single step Vancouver, British Columbia--(Newsfile Corp. - January 23, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company") is a developer of advanced technologies and services for the global pharmaceutical and chemical industries. The Company focuses on process innovation, particularly for the production of medicinal compounds and battery materials. Telescope announces it has fil Performance Overview Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index Return TELIF S&P/TSX Composite index YTD +14.72% +0.60% 1-Year +50.49% +18.10% 3-Year -37.26% +17.47%